REQUEST A DEMO
Total
USD $0.00
Search more companies

Gustavo Enrique Vergel Solano (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Gustavo Enrique Vergel Solano Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Gustavo Enrique Vergel Solano is an enterprise in Colombia, with the main office in Bogota D.C.. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on March 25, 2004. 7 (2025) employees currently work for Gustavo Enrique Vergel Solano. In 2024, the company reported a net sales revenue increase of 6.53%. Its’ total assets recorded a growth of 7.14%. In 2024, Gustavo Enrique Vergel Solano’s net profit margin decreased by 7.08%.

Headquarters
Cr 110 # 76 D 52
Bogota D.C.; Bogota D.C; Postal Code: 0923

Contact Details: Purchase the Gustavo Enrique Vergel Solano report to view the information.

Basic Information
Total Employees:
Purchase the Gustavo Enrique Vergel Solano report to view the information.
Financial Auditors:
Purchase the Gustavo Enrique Vergel Solano report to view the information.
Incorporation Date:
March 25, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gustavo Enrique Vergel Solano report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.53%
Total operating revenue
6.53%
Operating profit (EBIT)
-62.37%
Net Profit (Loss) for the Period
-62.37%
Total Assets
7.14%
Total Equity
7.14%
Operating Profit Margin (ROS)
-7.08%
Net Profit Margin
-7.08%
Return on Equity (ROE)
-104.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?